期刊文献+

非酒精性脂肪性肝病患者血清sICAM-1水平变化及意义 被引量:1

下载PDF
导出
摘要 目的探讨可溶性细胞间黏附分子-1(sICAM-1)在非酒精性脂肪性肝病(NAFLD)发生发展中的作用。方法 100例NAFLD患者,其中单纯性脂肪肝(NAFL)50例(NAFL组),脂肪性肝炎(NASH)50例(NASH组);健康查体者50例(对照组)。检测其血清sICAM-1水平及TC、TG、ALT、FPG、FINS等生化指标;分析sICAM-1与生化指标的相关性。结果 NASH组sICAM-1水平明显高于NAFL组及对照组(P均<0.05);NAFL组sICAM-1水平高于对照组,但无统计学差异。NASH组sICAM-1与TG、FINS、ALT呈正相关(r=0.268,0.264,0.637,P均<0.05),与TC、FPG无相关性(r=0.134,0.067,P均>0.05)。sICAM-1诊断NASH的ROC曲线下面积为0.79,敏感性97.1%,特异性53.3%。结论 sICAM-1可反映肝细胞损伤的严重程度,诊断NASH敏感性高,可作为鉴别NAFL、NASH的无创性辅助检查手段。
出处 《山东医药》 CAS 2014年第10期54-56,共3页 Shandong Medical Journal
  • 相关文献

参考文献4

二级参考文献20

  • 1Tortorella C, Sacco R, Orlando P, Salerno MT, Schiraldi O,Antonaci S. sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. Immunopharmacol Immunotoxicol 2000; 22:19-33.
  • 2de Caestecker JS. Bile acid therapy and markers of immunemediated damage in primary biliary cirrhosis. Eur J Gastroenterol Hepatol 1997; 9:145-147.
  • 3Granot E, Shouval D, Ashur Y. Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients.Mediators Inflamm 2001; 10:253-258.
  • 4Pugh RNH,Murray-Lyon IM, Dawson JL, Pietrosi MC, Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 1973; 60:646.
  • 5Douds AC, Lim AG, Jazrawi RP, Finlayson C, Maxwell DJ.Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity. J Hepatol 1997; 26:280-286.
  • 6Lo Iacono O, Garcia-Monzon C, Almasio P, Garcia-Buey L,Craxi A, Moreno-Otero R. Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-a. Aliment Pharmacol Ther 1998; 12:1091-1099.
  • 7Falleti E, Pirisi M, Fabris C, Bortolotti N, Soardo G, Gonano F, Batoli E. Circulating standard CD44 isoform in patients with liver disease: relationship with other solubile adhesion molecules and evaluation of diagnostic usefulness. Clinical Biochemistry 1997; 30:69-73.
  • 8Dejica D, Grigorescu M, Dejica V, Radu C, Neculoiu D. Serum levels of soluble intercellular-1 and vascular cell-1 adhesion molecules in chronic hepatitis C and the influence of interferon-alpha + ribavirin therapy. Rom J Gastroenterol 2002;11:277-283.
  • 9Radu C, Dejica D, Grigorescu M, Zaharie T, Necoloiu D. Correlation of sICAM-1 and sVCAM-1 level with biochemical, histological and viral findings in chronic hepatitis C after interferonalpha + ribavirin therapy. Rom J Gastroenterol 2003; 12:91-95.
  • 10Kaplanski G, Farnarier C, Payan MJ, Bongrand P, Durand JM. Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis. Dig Dis Sci 1997; 42:2277-2284.

共引文献1428

同被引文献30

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部